Characterization of CSF tryptophan metabolites in South African children with tuberculous meningitis
Ontefetse Neo Plaatjie1, A Marceline Tutu van Furth2, Regan Solomons3
1Department of Biochemistry, Biomedical and Molecular Metabolism (BioMMet), Faculty of Natural and Agricultural Sciences, North-West University, Potchefstroom, South Africa.
Insights
Cerebrospinal fluid (CSF) tryptophan depletion is common in childhood meningitis, but elevated kynurenine metabolites, particularly quinolinic acid, may help diagnose tuberculous meningitis (TBM). Quinolinic acid shows potential as a specific biomarker for TBM in children.
Area of Science:
- Neuroscience
- Infectious Diseases
- Biochemistry
Background:
- Tuberculous meningitis (TBM) is a severe form of tuberculosis, particularly dangerous in children due to immature immune systems.
- Diagnosis of TBM is challenging due to nonspecific symptoms, often leading to advanced disease at presentation.
- Tryptophan metabolism's role in pediatric TBM is understudied, despite its link to disease severity in adults.
Purpose of the Study:
- To investigate cerebrospinal fluid (CSF) tryptophan metabolism in pediatric TBM.
- To analyze both the serotonin and kynurenine pathways of tryptophan metabolism.
- To identify potential biomarkers for TBM in children.
Main Methods:
- Liquid chromatography-tandem mass spectrometry was used to measure tryptophan and its metabolites in CSF.
- 130 CSF samples were analyzed: 51 TBM, 49 non-meningitis controls (NMC), and 30 viral meningitis (VM) cases.
- Metabolite levels were correlated with CSF parameters and magnetic resonance imaging (MRI) findings.
Main Results:
- CSF tryptophan levels were significantly reduced in both TBM and VM compared to NMC, indicating a common immune response.
- Quinolinic acid was significantly elevated in TBM compared to both VM and NMC, showing potential diagnostic utility (AUCs 0.736-0.804).
- Quinolinic acid levels positively correlated with basal enhancement and hydrocephalus, key MRI features of TBM.
Conclusions:
- CSF tryptophan depletion is not specific to TBM, reflecting general immune activation.
- Elevated kynurenine pathway metabolites, especially quinolinic acid, suggest greater pathway activation in TBM.
- Quinolinic acid shows promise as a specific biomarker for pediatric TBM, correlating with disease-specific imaging findings.
Objectives:
Tuberculous meningitis (TBM), a severe form of tuberculosis, remains difficult to diagnose and is fatal if left untreated. Children are particularly vulnerable to the disease due to their immature immune systems. Often, diagnosis is delayed by nonspecific symptoms, leading to a more advanced stage of disease at presentation. Tryptophan metabolism has been linked to disease severity in adult TBM; however, its role in children remains largely unexplored. This study investigates cerebrospinal fluid (CSF) tryptophan metabolism, both the serotonin and kynurenine pathways, in paediatric TBM.
Methods:
We used liquid chromatography-tandem mass spectrometry to measure tryptophan and the metabolites of the tryptophan-kynurenine/serotonin pathways in a total of 130 CSF samples - TBM (n = 51), non-meningitis controls (NMC; n = 49) and viral meningitis (VM; n = 30). We further correlated the metabolites with CSF and magnetic resonance imaging (MRI) parameters.
Results:
CSF tryptophan levels were reduced in both TBM and VM compared to NMC, and the differences were statistically significant (NMC vs TBM, P < 0.001; NMC vs VM, P < 0.001). However, TBM and VM showed no significant differences (TBM vs VM, P > 0.05). Furthermore, tryptophan showed a moderate negative correlation with CSF lymphocyte count (r = -0.5). Quinolinic acid was the most elevated metabolite in TBM, distinguishing it from VM and NMC, with areas under the curve (AUCs) of 0.736 (95% confidence interval [CI]: 0.617-0.844) and 0.804 (95% CI: 0.716-0.887), respectively. Quinolinic acid also correlated positively with both basal enhancement (r = 0.51) and hydrocephalus (r = 0.58).
Conclusion:
CSF tryptophan depletion occurs in both TBM and VM, reflecting the activation of indoleamine-2,3-dioxygenase as a common immune response, and is therefore not disease-specific. However, elevated downstream kynurenine metabolites indicate greater pathway activation in TBM. Quinolinic acid could serve as a potential marker for TBM; its correlation with basal enhancement and hydrocephalus, key features of TBM, further suggests its specificity to TBM.
Related Concept Videos
Cerebrospinal Fluid
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain.
Inborn Errors of Metabolism
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Viral Meningitis
Cryptococcal Meningitis
Brain Abscess l: Introduction


![Radiosynthesis of 1-2-[18F]Fluoroethyl-L-Tryptophan using a One-pot, Two-step Protocol](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F63025.jpg&w=3840&q=50)